<DOC>
	<DOC>NCT01914211</DOC>
	<brief_summary>This is an observational, prospective study to evaluate the role of tranexamic acid in reducing blood transfusion in neonates undergoing cardiopulmonary bypass.</brief_summary>
	<brief_title>The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects, Congenital</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>All neonates undergoing arterial switch or aortic arch procedure utilizing cardiopulmonary bypass (CPB). Jehovah's witness patients.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>